83 FR 23471 - Request for Information for the Development of the Fiscal Year 2021-2023 Trans-NIH Strategic Plan for HIV and HIV-Related Research
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 83, Issue 98 (May 21, 2018)
National Institutes of Health
Federal Register Volume 83, Issue 98 (May 21, 2018)
| Page Range | 23471-23472 | |
| FR Document | 2018-10784 |
[Federal Register Volume 83, Number 98 (Monday, May 21, 2018)] [Notices] [Pages 23471-23472] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-10784] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Information for the Development of the Fiscal Year 2021-2023 Trans-NIH Strategic Plan for HIV and HIV-Related Research AGENCY: National Institutes of Health, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: Through this Request for Information (RFI), the Office of AIDS Research (OAR) in the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), National Institutes of Health (NIH), invites feedback from investigators in academia, industry, health care professionals, patient advocates and health advocacy organizations, scientific or professional organizations, federal agencies, community, and other interested constituents on the development of the fiscal year (FY) 2021-2023 Trans-NIH Strategic Plan for HIV and HIV-Related Research (the Plan). The Plan is designed to identify and articulate future directions to maximize the NIH's investments in HIV research. DATES: The OAR's Request for Information is open for public comment for a period of 30 days. Comments must be received by June 20, 2018 to ensure consideration. After the public comment period has closed, the comments received by OAR will be considered in a timely manner for the development of the FY 2021-2023 Trans-NIH Strategic Plan for HIV and HIV-related Research. ADDRESSES: Submissions may be electronically entered at https://grants.nih.gov/grants/rfi/rfi.cfm?ID=76. FOR FURTHER INFORMATION CONTACT: Questions about this request for information should be directed to the Office of AIDS Research, National Institutes of Health, email: [email protected], 5601 Fishers Lane Rockville, Maryland 20852. SUPPLEMENTARY INFORMATION: To respond this RFI, go to the following web address: http://grants.nih.gov/grants/rfi/rfi.cfm?ID=76. As legislatively mandated, OAR plans and coordinates research through the development of an annual Trans-NIH Strategic Plan for HIV and HIV-Related Research that articulates the overarching HIV research priorities and serves as the framework for developing the trans-NIH HIV research budget. OAR oversees and coordinates the conduct and support of all HIV research activities across the NIH Institutes and Centers (ICs). The NIH-sponsored HIV research programs include both extramural and intramural research, buildings and facilities, research training, program evaluation, and supports a comprehensive portfolio of research representing a broad range of basic, clinical, behavioral, social sciences, and translational research on HIV and its associated coinfections and comorbidities. The Plan provides information about the NIH's HIV research priorities to the scientific community, Congress, community stakeholders, HIV-affected communities, and the broad public at large. The fiscal year 2018 Trans-NIH Plan for HIV-Related Research was recently distributed on the OAR website: (https://www.oar.nih.gov/strategic_plan/plan_18.asp). The current overarching priorities for HIV/AIDS research are defined in the NIH Director's Statement of August 12, 2015, and Guide Notice NOT-OD-15-137 (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html). High Priority topics of research for support include: (1) Reducing the incidence of HIV/AIDS; (2) Developing the next generation of HIV therapies; (3) Identifying strategies towards a cure; (4) Improving the prevention and treatment of HIV-associated comorbidities, coinfections, and complications; and (5) Cross-cutting areas that includes basic research, behavioral and social sciences research, health disparities, trainings, capacity- building, and infrastructure. This RFI is for planning purposes only and should not be construed as a solicitation for applications or proposals, or as an obligation in any way on the part of the United States Federal Government. The Federal [[Page 23472]] Government will not pay for the preparation of any information submitted or for the government's use. Additionally, the government cannot guarantee the confidentiality of the information provided. Dated: May 14, 2018. Lawrence A. Tabak, Deputy Director, National Institutes of Health. [FR Doc. 2018-10784 Filed 5-18-18; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 83, No. 98 / Monday, May 21, 2018 / Notices 23471
determined as follows: (1) Primary New entities may be added to the Health Institutes of Health, email:
medical care HPSAs with scores of 18 Workforce Connector during a Site NIHOARRFI@nih.gov, 5601 Fishers
and above are authorized for the Application competition. Likewise, Lane Rockville, Maryland 20852.
assignment of NHSC scholars who are entities that no longer meet eligibility SUPPLEMENTARY INFORMATION: To
primary care physicians, primary care criteria, including those sites whose 3- respond this RFI, go to the following
nurse practitioners, primary care year approval as an NHSC service site web address: http://grants.nih.gov/
physician assistants, or certified nurse has lapsed or whose HPSA designation grants/rfi/rfi.cfm?ID=76.
midwives; (2) mental health HPSAs has been withdrawn or whose As legislatively mandated, OAR plans
with scores of 18 and above are withdrawal is being processed, will be and coordinates research through the
authorized for the assignment of NHSC removed from the priority listing. development of an annual Trans-NIH
scholars who are psychiatrists, mental Dated: May 15, 2018. Strategic Plan for HIV and HIV-Related
health nurse practitioners, or mental Research that articulates the overarching
George Sigounas,
health physician assistants; and (3) HIV research priorities and serves as the
dental HPSAs with scores of 18 and Administrator.
[FR Doc. 2018–10699 Filed 5–18–18; 8:45 am]
framework for developing the trans-NIH
above are authorized for the assignment HIV research budget. OAR oversees and
of NHSC scholars who are dentists. The BILLING CODE 4165–15–P
coordinates the conduct and support of
NHSC has determined that a minimum all HIV research activities across the
HPSA score of 18 for all service-ready NIH Institutes and Centers (ICs). The
NHSC scholars will enable it to meet its DEPARTMENT OF HEALTH AND
HUMAN SERVICES NIH-sponsored HIV research programs
statutory obligation to identify a number include both extramural and intramural
of entities eligible for NHSC scholar research, buildings and facilities,
National Institutes of Health
placement that is at least equal to, but research training, program evaluation,
not greater than, twice the number of Request for Information for the and supports a comprehensive portfolio
NHSC scholars available to serve in the Development of the Fiscal Year 2021– of research representing a broad range of
2018–2019 placement cycle. 2023 Trans-NIH Strategic Plan for HIV basic, clinical, behavioral, social
Beginning on April 1, 2019, and on or and HIV-Related Research sciences, and translational research on
about April 1 of each subsequent year,
HIV and its associated coinfections and
HRSA will publish on its website AGENCY: National Institutes of Health,
comorbidities.
https://connector.hrsa.gov/, the HPSA HHS.
scores used to determine priority for The Plan provides information about
ACTION: Notice. the NIH’s HIV research priorities to the
assignment of NHSC scholars for
placement cycles after September 30, SUMMARY: Through this Request for scientific community, Congress,
2019, and entities that would receive Information (RFI), the Office of AIDS community stakeholders, HIV-affected
priority for the placement of NHSC Research (OAR) in the Division of communities, and the broad public at
scholars. Entities wishing to provide Program Coordination, Planning, and large. The fiscal year 2018 Trans-NIH
additional data and information to Strategic Initiatives (DPCPSI), National Plan for HIV-Related Research was
support their inclusion on the proposed Institutes of Health (NIH), invites recently distributed on the OAR
list of entities receiving priority in feedback from investigators in website: (https://www.oar.nih.gov/
assignment of NHSC scholars, or to academia, industry, health care strategic_plan/plan_18.asp).
support a higher priority determination, professionals, patient advocates and The current overarching priorities for
must do so in writing no later than May health advocacy organizations, scientific HIV/AIDS research are defined in the
1, 2019, or within 30 days following the or professional organizations, federal NIH Director’s Statement of August 12,
publication of a revised list in agencies, community, and other 2015, and Guide Notice NOT–OD–15–
subsequent years. interested constituents on the 137 (https://grants.nih.gov/grants/
Sites wishing to request an additional development of the fiscal year (FY) guide/notice-files/NOT-OD-15-
scholar must complete an Additional 2021–2023 Trans-NIH Strategic Plan for 137.html).
Scholar Request form available at http:// HIV and HIV-Related Research (the High Priority topics of research for
nhsc.hrsa.gov/downloads/additional Plan). The Plan is designed to identify support include:
requestform.pdf. NHSC-approved sites and articulate future directions to (1) Reducing the incidence of HIV/
that do not meet the authorized maximize the NIH’s investments in HIV AIDS;
threshold HPSA may post job openings research. (2) Developing the next generation of
on the Health Workforce Connector; HIV therapies;
DATES: The OAR’s Request for
however, scholars seeking placement (3) Identifying strategies towards a
Information is open for public comment cure;
will be advised that they can only for a period of 30 days. Comments must
compete for positions at sites that meet (4) Improving the prevention and
be received by June 20, 2018 to ensure treatment of HIV-associated
the threshold that is in effect at the time consideration. After the public comment
they seek to be placed at an NHSC- comorbidities, coinfections, and
period has closed, the comments complications; and
approved site. Although vacancies in received by OAR will be considered in
HPSAs that have scores less than the (5) Cross-cutting areas that includes
a timely manner for the development of basic research, behavioral and social
authorized threshold are not eligible for the FY 2021–2023 Trans-NIH Strategic
scholar placements, such vacancies will sciences research, health disparities,
Plan for HIV and HIV-related Research. trainings, capacity-building, and
sradovich on DSK3GMQ082PROD with NOTICES
be used by the NHSC when evaluating
ADDRESSES: Submissions may be infrastructure.
the HPSA threshold score for the next
annual scholarship placement cycle. electronically entered at https:// This RFI is for planning purposes
grants.nih.gov/grants/rfi/rfi.cfm?ID=76. only and should not be construed as a
Application Requests FOR FURTHER INFORMATION CONTACT: solicitation for applications or
The list of HPSAs and entities eligible Questions about this request for proposals, or as an obligation in any
to receive priority for the placement of information should be directed to the way on the part of the United States
NHSC scholars is updated periodically. Office of AIDS Research, National Federal Government. The Federal
VerDate Sep<11>2014 18:20 May 18, 2018 Jkt 244001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\21MYN1.SGM 21MYN1](https://thefederalregister.org/doc/83_FR_23569/page/1.svg)
![23472 Federal Register / Vol. 83, No. 98 / Monday, May 21, 2018 / Notices
Government will not pay for the Review Group; Macromolecular Structure Scientific Review, National Institutes of
preparation of any information and Function D Study Section. Health, 6701 Rockledge Drive, Room 4168,
submitted or for the government’s use. Date: June 13, 2018. MSC 7806, Bethesda, MD 20892, (301) 435–
Time: 9:00 a.m. to 8:00 p.m. 1726, greenbergwa@csr.nih.gov.
Additionally, the government cannot
Agenda: To review and evaluate grant Name of Committee: Center for Scientific
guarantee the confidentiality of the applications. Review Special Emphasis Panel; Auditory
information provided. Place: The Allerton Hotel, 701 North Science.
Dated: May 14, 2018. Michigan Avenue, Chicago, IL 60611. Date: June 14, 2018.
Lawrence A. Tabak, Contact Person: James W. Mack, Ph.D., Time: 8:00 a.m. to 6:00 p.m.
Scientific Review Officer, Center for Agenda: To review and evaluate grant
Deputy Director, National Institutes of Health. Scientific Review, National Institutes of applications.
[FR Doc. 2018–10784 Filed 5–18–18; 8:45 am] Health, 6701 Rockledge Drive, Room 4154, Place: Washington Marriott Georgetown,
BILLING CODE 4140–01–P MSC 7806, Bethesda, MD 20892, (301) 435– 1221 22nd Street NW, Washington, DC
2037, mackj2@csr.nih.gov. 20037.
Name of Committee: Center for Scientific Contact Person: Jana Drgonova, Ph.D.,
DEPARTMENT OF HEALTH AND Review Special Emphasis Panel; Rodent Scientific Review Officer, Center for
HUMAN SERVICES Testing Centers for Development of Reporter Scientific Review, National Institutes of
Systems and Evaluation of Somatic Cell Health, 6701 Rockledge Drive, Room 5213,
National Institutes of Health Genome Editing Tools (U42). Bethesda, MD 20892, 301–827–2549,
Date: June 13, 2018. jdrgonova@mail.nih.gov.
Center for Scientific Review; Notice of Time: 10:30 a.m. to 11:00 p.m. Name of Committee: Healthcare Delivery
Closed Meetings Agenda: To review and evaluate grant and Methodologies Integrated Review Group;
applications. Biostatistical Methods and Research Design
Pursuant to section 10(d) of the Place: National Institutes of Health, 6701 Study Section.
Federal Advisory Committee Act, as Rockledge Drive, Bethesda, MD 20892 Date: June 14–15, 2018.
amended, notice is hereby given of the (Virtual Meeting). Time: 8:00 a.m. to 6:00 p.m.
following meetings. Contact Person: Alok Mulky, Ph.D., Agenda: To review and evaluate grant
Scientific Review Officer, Center for applications.
The meetings will be closed to the
Scientific Review, National Institutes of Place: Embassy Suites by Hilton Chicago
public in accordance with the Health, 6701 Rockledge Drive, Room 4203, Downtown, 600 North State Street, Chicago,
provisions set forth in sections Bethesda, MD 20892, (301) 435–3566, IL 60654.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., alok.mulky@nih.gov. Contact Person: Peter J. Kozel, Ph.D.,
as amended. The grant applications and Name of Committee: Center for Scientific Scientific Review Officer, Center for
the discussions could disclose Review Special Emphasis Panel; Academic Scientific Review, National Institutes of
confidential trade secrets or commercial Research Enhancement Award. Health, 6701 Rockledge Drive, Room 3139,
property such as patentable material, Date: June 13, 2018. Bethesda, MD 20892, 301–435–1116, kozelp@
and personal information concerning Time: 1:00 p.m. to 4:00 p.m. mail.nih.gov.
individuals associated with the grant Agenda: To review and evaluate grant Name of Committee: Center for Scientific
applications, the disclosure of which applications. Review Special Emphasis Panel; Member
Place: National Institutes of Health, 6701 Conflict: Respiratory Sciences.
would constitute a clearly unwarranted
Rockledge Drive, Bethesda, MD 20892 Date: June 14–15, 2018.
invasion of personal privacy. (Virtual Meeting). Time: 9:00 a.m. to 5:00 p.m.
Name of Committee: Center for Scientific Contact Person: Reigh-Yi Lin, Ph.D., Agenda: To review and evaluate grant
Review Special Emphasis Panel; PAR Panel: Scientific Review Officer, Center for applications.
Neural Regulation of Cancer. Scientific Review, National Institutes of Place: National Institutes of Health, 6701
Date: June 7, 2018. Health, 6701 Rockledge Drive, Bethesda, MD Rockledge Drive, Bethesda, MD 20892
Time: 2:00 p.m. to 5:00 p.m. 20892, 301–827–6009, lin.reigh-yi@nih.gov. (Virtual Meeting).
Agenda: To review and evaluate grant Name of Committee: Immunology Contact Person: Ghenima Dirami, Ph.D.,
applications. Integrated Review Group; Transplantation, Scientific Review Officer, Center for
Place: National Institutes of Health, 6701 Tolerance, and Tumor Immunology Study Scientific Review, National Institutes of
Rockledge Drive, Bethesda, MD 20892 Section. Health, 6701 Rockledge Drive, Room 4122,
(Telephone Conference Call). Date: June 14–15, 2018. MSC 7814, Bethesda, MD 20892, 240–498–
Contact Person: Manzoor Zarger, Ph.D., Time: 8:00 a.m. to 5:00 p.m. 7546, diramig@csr.nih.gov.
Scientific Review Officer, Center for Agenda: To review and evaluate grant Name of Committee: Center for Scientific
Scientific Review, National Institutes of applications. Review Special Emphasis Panel; Par Panel:
Health, 6701 Rockledge Drive, Room 6208, Place: Washington Plaza Hotel, 10 Thomas Academic-Industrial Partnerships Research
MSC 7804, Bethesda, MD 20892, (301) 435– Circle NW, Washington, DC 20005. for Cancer Diagnosis and Treatment.
2477, zargerma@csr.nih.gov. Contact Person: Jin Huang, Ph.D., Date: June 15, 2018.
Name of Committee: Center for Scientific Scientific Review Officer, Center for Time: 8:30 a.m. to 5:00 p.m.
Review Special Emphasis Panel; Program Scientific Review, National Institutes of Agenda: To review and evaluate grant
Projects: Drug Abuse. Health, 6701 Rockledge Drive, Room 4199, applications.
Date: June 8, 2018. MSC 7812, Bethesda, MD 20892, 301–435– Place: National Institutes of Health, 6701
Time: 11:00 a.m. to 2:00 p.m. 1230, jh377p@nih.gov. Rockledge Drive, Bethesda, MD 20892.
Agenda: To review and evaluate grant Name of Committee: Biological Chemistry Contact Person: Guo Feng Xu, Ph.D.,
applications. and Macromolecular Biophysics Integrated Scientific Review Officer, Center for
Place: Sheraton Seattle Hotel, 1400 6th Review Group; Macromolecular Structure Scientific Review, National Institutes of
Avenue, Seattle, WA 98101. and Function C Study Section. Health, 6701 Rockledge Drive, Room 5122,
sradovich on DSK3GMQ082PROD with NOTICES
Contact Person: Jasenka Borzan, Ph.D., Date: June 14, 2018. MSC 7854, Bethesda, MD 20892, 301–237–
Scientific Review Officer, Center for Time: 8:00 a.m. to 7:00 p.m. 9870, xuguofen@csr.nih.gov.
Scientific Review, National Institutes of Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance
Health, 6701 Rockledge Drive Room 4214, applications. Program Nos. 93.306, Comparative Medicine;
Bethesda, MD 20892–7814, 301–435–1787, Place: The Allerton Hotel, 701 North 93.333, Clinical Research, 93.306, 93.333,
borzanj@csr.nih.gov. Michigan Avenue, Chicago, IL 60611. 93.337, 93.393–93.396, 93.837–93.844,
Name of Committee: Biological Chemistry Contact Person: William A. Greenberg, 93.846–93.878, 93.892, 93.893, National
and Macromolecular Biophysics Integrated Ph.D., Scientific Review Officer, Center for Institutes of Health, HHS)
VerDate Sep<11>2014 18:20 May 18, 2018 Jkt 244001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\21MYN1.SGM 21MYN1](https://thefederalregister.org/doc/83_FR_23569/page/2.svg)
Document Created: 2018-11-02 11:08:13
Document Modified: 2018-11-02 11:08:13
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | The OAR's Request for Information is open for public comment for a period of 30 days. Comments must be received by June 20, 2018 to ensure consideration. After the public comment period has closed, the comments received by OAR will be considered in a timely manner for the development of the FY 2021-2023 Trans-NIH Strategic Plan for HIV and HIV-related Research. | |
| Contact | Questions about this request for information should be directed to the Office of AIDS Research, National Institutes of Health, email: [email protected], 5601 Fishers Lane Rockville, Maryland 20852. | |
| FR Citation | 83 FR 23471 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR